| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/15/2007 | WO2006060127A3 COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE |
| 03/15/2007 | WO2006055922A8 Anthranilamide insecticides |
| 03/15/2007 | WO2006024823A9 Pyrimidine sulphonamide derivatives as chemokine receptor modulators |
| 03/15/2007 | US20070060756 Process for the preparation of desloratadine |
| 03/15/2007 | US20070060754 Alkoxy substituted imidazoquinolines |
| 03/15/2007 | US20070060753 Process for preparing intermediates useful to prepare certain antibacterial n-formyl hydroxylamines |
| 03/15/2007 | US20070060629 Large conductance calcium-activated k channel opener |
| 03/15/2007 | US20070060616 Methods for treating, preventing and managing chronic lymphocytic leukemia with indazole compounds |
| 03/15/2007 | US20070060613 N-(4-(6,7-Dimethoxyquinolin-4-yloxy)-3-fluorophenyl)-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide; inhibit the protein tyrosine kinase activity of growth factor receptors such as c-Met, thereby making them useful as anti-cancer agents |
| 03/15/2007 | US20070060601 Mitotic kinesin inhibitors |
| 03/15/2007 | US20070060596 Selective modulators of prostaglandin E2 at EP1 receptors; analgesics, antiinflammatory agents; neurodegenerative diseases, bone or renal disorders; 1-({5-bromo-2-[(phenylmethyl)oxy]phenyl}methyl)-5-methyl-1H-pyrazole-3-carboxylic acid |
| 03/15/2007 | US20070060594 Pyridinyl acetonitriles |
| 03/15/2007 | US20070060592 Chemokine receptor antagonists and methods of use therefor |
| 03/15/2007 | US20070060591 Amine substituted (dihydro- or tetrahydro-)quinoline, pyranopyridine, thiapyranopyridine, or naphthyridine derivatives as chemokine receptor modulators; lymphadenopathy associated, human T-cell leukemia/lymphoma, and/or feline immunodeficiency virus infections |
| 03/15/2007 | US20070060585 2-[1-Phenyl-2-(2-trifluoromethyl-phenyl)-ethyl]-morpholine-4-carboxylic acid benzyl ester, for example; for the treatment of disturbances of vegetative function associated with affective, anxiety and cognitive disorders |
| 03/15/2007 | US20070060583 2-tert-Butyl-N,N-diethyl-1-{[1-methylpiperidin-2-yl]methyl}-1H-benzimidazole-5-carboxamide; cannabinoid receptors agonists; analgesic, anticarcinogenic, antiinflammatory, anxiolytic agent; neurodegenerative diseases; gastrointestinal and cardiovascular disorders |
| 03/15/2007 | US20070060582 1,4-Disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases |
| 03/15/2007 | US20070060581 1-Sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands |
| 03/15/2007 | US20070060572 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
| 03/15/2007 | US20070060570 Sulfopyrroles |
| 03/15/2007 | US20070060569 Azacycloalkyl substituted acetic acid derivatives for use as MMP inhibitors |
| 03/15/2007 | US20070060566 Benzazepine derivatives as histamine h3 antagonists |
| 03/15/2007 | US20070060556 Barium salt of benzimidazole derivative |
| 03/15/2007 | US20070057250 Light-emitting device, organic compound and display |
| 03/15/2007 | US20070056120 Cationic diaminopyrazoles, a process for producing them and colorants containing these compounds |
| 03/15/2007 | DE102004002885B4 Neue medizinisch einsetzbare Pyrrolalkaloide: Verfahren zu ihrer Isolierung, Synthese, sie enthaltende Arzneimittel und deren Verwendung New medical usable pyrrole alkaloids: methods for their isolation, synthesis, pharmaceutical compositions containing them and their use |
| 03/15/2007 | CA2621470A1 Bicyclic aromatic substituted pyridone derivative |
| 03/15/2007 | CA2621445A1 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 03/15/2007 | CA2620472A1 Substituted benzimidazoles as kinase inhibitors |
| 03/14/2007 | EP1762568A1 Pyrazole derivatives |
| 03/14/2007 | EP1762567A1 Pyrazole derivatives for treating HIV |
| 03/14/2007 | EP1761539A1 Indole derivative and use for treatment of cancer |
| 03/14/2007 | EP1761531A1 Imidazole variants as modulators of gaba receptor for the treatment of gi disorders |
| 03/14/2007 | EP1761522A1 Compounds and methods for treating dyslipidemia |
| 03/14/2007 | EP1761521A1 Compounds and methods for treating dyslipidemia |
| 03/14/2007 | EP1761520A1 Kinase inhibitors |
| 03/14/2007 | EP1761519A1 Indole derivatives as histamine receptor antagonists |
| 03/14/2007 | EP1761518A1 Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors |
| 03/14/2007 | EP1761517A1 Novel imidazoles and triazoles, the production thereof, and the use of the same as medicaments |
| 03/14/2007 | EP1761516A1 2, 4, 5, 6-substituted pyrimidines, method for the production and use thereof for combating parasitic fungi |
| 03/14/2007 | EP1761515A1 2-(hetero-)aryl substituted tetrahydroquinoline derivatives |
| 03/14/2007 | EP1761510A1 Method for producing 4-(benzimidazolylmethylamino)-benzamidines |
| 03/14/2007 | EP1761506A1 Substituted quinazolones as anti-cancer agents |
| 03/14/2007 | EP1761505A1 Pyrimidine urea derivatives as kinase inhibitors |
| 03/14/2007 | EP1761497A2 Azadecalin glucocorticoid receptor modulators |
| 03/14/2007 | EP1761494A1 Chemical compounds i |
| 03/14/2007 | EP1562936B1 Therapeutic piperazine compounds |
| 03/14/2007 | EP1517895B1 8-(biaryl) quinoline pde4 inhibitors |
| 03/14/2007 | EP1515949B1 Mitotic kinesin inhibitors |
| 03/14/2007 | EP1406897B1 Compounds |
| 03/14/2007 | EP1284968B1 Method of combating undesired plant growth on cereals |
| 03/14/2007 | EP1246802B1 4-aminopicolinates and their use as herbicides |
| 03/14/2007 | EP1242083B1 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them |
| 03/14/2007 | EP1045837B1 Monomeric and dimeric arylisoquinoline alkaloids and derivatives thereof |
| 03/14/2007 | EP0989978B1 Tricyclic keto amide derivatives useful as farnesyl protein transferase inhibitors |
| 03/14/2007 | CN1930157A Silylierte carboxamide |
| 03/14/2007 | CN1930148A Polymorphic and amorphous forms of 2,5-dimethyl-2h-pyrazole-3-carboxylic acid {2-fluoro-5-[3-((e)-2-pyridin-2-yl-vinyl)-1h-indasol-6-ylamino]-phenyl}-amide |
| 03/14/2007 | CN1930147A Vla－4拮抗剂 Vla-4 antagonists |
| 03/14/2007 | CN1930146A Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists |
| 03/14/2007 | CN1930145A Cycloalkanopyridine derivative |
| 03/14/2007 | CN1930144A 3-'4-heterocyclyl -1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases |
| 03/14/2007 | CN1930143A MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles |
| 03/14/2007 | CN1930133A 苯并咪唑衍生物 Benzimidazole derivatives |
| 03/14/2007 | CN1930131A 2H- or 3H-benzo[e]indazol-1-yle carbamate derivatives, the preparation and therapeutic use thereof |
| 03/14/2007 | CN1930130A 1-phenyl and 1-pyridylpyrazole derivatives and their use as pesticides |
| 03/14/2007 | CN1930127A Process for the synthesis of cxcr4 antagonist |
| 03/14/2007 | CN1930126A 吡啶酮衍生物 Pyridine derivatives |
| 03/14/2007 | CN1929920A Use of metal complex compounds comprising pyridine, pyrimidine or S-triazine derived ligands as catalysts for oxidations with organic peroxy acids and/or precursors of organic peroxy acids and H2O2 |
| 03/14/2007 | CN1929848A Benzodiazepines for treating or preventing or preventing RSV infection |
| 03/14/2007 | CN1929847A Fasudil-containing preparation and method of improving stability thereof |
| 03/14/2007 | CN1929738A Substituted 4-(4-trifluoromethylpyrazolyl)-pyrimidines serving as herbicides |
| 03/14/2007 | CN1927859A Substituted oxdiazole or triazole thioketone compounds, preparation and application thereof |
| 03/14/2007 | CN1304691C Chlorohydrin and cationic compounds having high affinity for pulp paper |
| 03/14/2007 | CN1304395C New camptothecin analogue compounds, a process for their preparation and pharmaceutical compositions containing them |
| 03/14/2007 | CN1304391C Preparation method of hydrobromic acid antifebrile dichroanone |
| 03/14/2007 | CN1304390C Novel gamma secretase inhibitors |
| 03/14/2007 | CN1304389C Piperidine derivatives useful as CCR5 antagonists |
| 03/14/2007 | CN1304382C New p2X* receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases |
| 03/14/2007 | CN1304377C Metalloproteinase inhibitors |
| 03/14/2007 | CN1304375C Pyrazoloanthrone and derivatives thereof as JNK inhibitors and their compositions |
| 03/14/2007 | CN1304374C Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition |
| 03/14/2007 | CN1304365C Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 03/14/2007 | CN1304347C Method for refining waste tobacco primary extract at subcritical DMC |
| 03/14/2007 | CN1304005C Combinations of receptor tyrosine kinase inhibitor with a1-acidic glycoprotein binding organic compound |
| 03/13/2007 | US7189864 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors |
| 03/13/2007 | US7189855 Process for production of phenoxy-substituted 2-pyridone compounds |
| 03/13/2007 | US7189854 Reacting 4-(2-hydroxyethyl)piperazine and 2-((2-methyl,6-chloro-pyrimidin-4-yl)-amino),5-(2-chloro,6-methyl-phenyl)thiazole to obtain 2-((2-hydroxyethyl)piperazin-4-yl)-(2-methylpyrimidin-6,4-ylene)amino-),5-(2-chloro,6-methyl-phenyl)thiazole; antiarthritic,-tumor, -carcinogentic agents; immunology |
| 03/13/2007 | US7189756 Pyrrolidine derivatives |
| 03/13/2007 | US7189755 Pyrrolidine melanocortin-specific compounds |
| 03/13/2007 | US7189754 Pyrrolidine ester derivatives with oxytocin modulating activity |
| 03/13/2007 | US7189745 For use in therapy of diseases, in a mammal, in which inappropriate, excessive or undesirable angiogenesis has occurred and/or where excessive Tie2 receptor activity has occurred, cytokine antagonist, antiarthritic agent, for therapy of diabetic retinopathy |
| 03/13/2007 | US7189744 Crystals of benzimidazole compounds |
| 03/13/2007 | US7189743 To inhibit thrombus formation |
| 03/13/2007 | US7189741 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 03/13/2007 | US7189739 Antiinflammatory agents; cardiovascular disorders; rheumatic disorders |
| 03/13/2007 | US7189738 Substituted isoindoles and their use thereof |
| 03/13/2007 | US7189728 Inhibitors of dipeptidyl peptidase IV |
| 03/13/2007 | US7189727 Guanidino compounds |
| 03/13/2007 | US7189726 Benzofuran derivatives as inhibitors of p38-α kinase |
| 03/13/2007 | US7189724 For therapy of viral diseases |